Plasma and Dietary Vitamin E in Relation to Incidence of Type 2 Diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS)
Overview
Affiliations
Objective: To evaluate the association of vitamin E with incidence of type 2 diabetes and to do so separately among individuals who did and those who did not report regular use of vitamin supplementation.
Research Design And Methods: The Insulin Resistance Atherosclerosis Study (IRAS) included 895 nondiabetic adults at baseline (including 303 with impaired glucose tolerance [IGT]), 148 of whom developed type 2 diabetes according to World Health Organization (WHO) criteria during the 5-year follow-up. At baseline, dietary vitamin E was estimated by a validated food frequency interview, usual supplement use was confirmed by supplement label, and plasma alpha-tocopherol was measured. Analyses were conducted separately for individuals who did (n = 318) and did not (n = 577) use vitamin E supplements.
Results: Among supplement nonusers, reported mean intake of vitamin E (mg alpha-tocopherol equivalents [alpha-TE]) did not differ between those who remained nondiabetic (n = 490) and those who developed diabetes (n = 87) (10.5 +/- 5.5 vs. 9.5 +/- 4.8 [means +/- SD], respectively, NS). After adjustment for demographic variables, obesity, physical activity, and other nutrients, the association remained nonsignificant (odds ratio [OR] 0.80, 95% CI 0.13-5.06) for the highest level of intake (> or =20 mg alpha-TE) compared with the lowest level (1-4 alpha-TE). However, results for plasma concentration of alpha-tocopherol showed a significant protective effect both before and after adjustment for potential confounders (adjusted OR 0.12, 95% CI 0.02-0.68, for the highest quintile vs. the lowest quintile; overall test for trend, P < 0.01). Among individuals who reported habitual use of vitamin E supplements (at least once per month in the year before baseline; 259 remained nondiabetic and 59 developed diabetes), no protective effect was observed for either reported intake of vitamin E or plasma concentration of alpha-tocopherol
Conclusions: A protective effect of vitamin E may exist within the range of intake available from food. This effect may go undetected within studies of high-dose supplement use, which appears to hold no additional protective benefit.
Lai J, Godfrey K, Ong C, Tan K, Yap F, Chong Y Nutrients. 2023; 15(20).
PMID: 37892496 PMC: 10610276. DOI: 10.3390/nu15204421.
Vitamin E and Non-Communicable Diseases: A Review.
Ciarcia G, Bianchi S, Tomasello B, Acquaviva R, Malfa G, Naletova I Biomedicines. 2022; 10(10).
PMID: 36289735 PMC: 9599164. DOI: 10.3390/biomedicines10102473.
Chua G, Phang S, Wong Y, Ho L, Palanisamy U, Abdul Kadir K Nutrients. 2020; 12(12).
PMID: 33261162 PMC: 7761176. DOI: 10.3390/nu12123659.
Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy?.
Ziegler M, Wallert M, Lorkowski S, Peter K Antioxidants (Basel). 2020; 9(10).
PMID: 33003543 PMC: 7600583. DOI: 10.3390/antiox9100935.
Circulating vitamin E and cardiometabolic measures: a Mendelian randomization analysis.
Fan C, Huang T, Kong X, Zhang X, Zou Z, Xiao J J Clin Biochem Nutr. 2019; 65(2):160-169.
PMID: 31592210 PMC: 6769411. DOI: 10.3164/jcbn.19-12.